A Phase 3 company should not be constantly dropping and losing...

A Phase 3 company should not be constantly dropping and losing its value, even during Covid and the war in Ukraine. Yes, the world changes all the time, and markets react on a daily basis to both positive and negative events.

Through it all, PAR is still greenlit by the FDA for Phase 3 trials. There is value in that, and that alone, so this dropping under $1 is a major red flag.

Marketing has been horrible for a long time, pretty much starting with the amateur NFL video. That video was horrendous and it did nothing to publicly promote the benefits of the drug for the players treated.

Rennie's slip-ups in the so-called 'fireside chats,' along with missed and ignored timelines, and an unexpected, and poorly executed CR, have all contributed to this negative market sentiment.

Skerrett's droll and unispiring public persona irks me no end. She does nothing to evoke excitement for the drug and its future possibilities. She is not the right front and centre mouthpiece.

Put simply, we are a Phase 3 company with the wrong people steering the ship. Money will soon be running out, and unless things turn around, and fast, a low ball takeover is a very real probability...or another CR! That's a lose/lose situation for all current, loyal, long term shareholders.